Publicaciones en colaboración con investigadores/as de National Cancer Institute (124)

2024

  1. Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis

    eBioMedicine, Vol. 100

  2. Identification of genetically predicted DNA methylation markers associated with non–small cell lung cancer risk among 34,964 cases and 448,579 controls

    Cancer, Vol. 130, Núm. 6, pp. 913-926

  3. Impact of individual level uncertainty of lung cancer polygenic risk score (PRS) on risk stratification

    Genome Medicine, Vol. 16, Núm. 1

  4. Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies

    Cancer Epidemiology Biomarkers and Prevention, Vol. 33, Núm. 3, pp. 389-399

2023

  1. Association between duration of smoking abstinence before non-small-cell lung cancer diagnosis and survival: a retrospective, pooled analysis of cohort studies

    The Lancet. Public health, Vol. 8, Núm. 9, pp. e691-e700

  2. Candidate pathway analysis of surfactant proteins identifies CTSH and SFTA2 that influences lung cancer risk

    Human molecular genetics, Vol. 32, Núm. 18, pp. 2842-2855

  3. Genome-wide Association Study of Bladder Cancer Reveals New Biological and Translational Insights

    European Urology, Vol. 84, Núm. 1, pp. 127-137

  4. Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions

    Journal of the National Cancer Institute, Vol. 115, Núm. 6, pp. 712-732

  5. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

    Nature Communications, Vol. 14, Núm. 1

  6. Mosaic Chromosomal Alterations Are Associated With Increased Lung Cancer Risk: Insight From the INTEGRAL-ILCCO Cohort Analysis

    Journal of Thoracic Oncology, Vol. 18, Núm. 8, pp. 1003-1016

2022

  1. A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians

    Journal of Thoracic Oncology, Vol. 17, Núm. 8, pp. 974-990

  2. Accounting for EGFR Mutations in Epidemiologic Analyses of Non–Small Cell Lung Cancers: Examples Based on the International Lung Cancer Consortium Data

    Cancer Epidemiology Biomarkers and Prevention, Vol. 31, Núm. 3, pp. 679-687

  3. Adapting Decision Rules to Estimate Occupational Metalworking Fluid Exposure in a Case-Control Study of Bladder Cancer in Spain

    Annals of Work Exposures and Health, Vol. 66, Núm. 3, pp. 392-401

  4. Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer

    Nature Genetics, Vol. 54, Núm. 8, pp. 1167-1177

  5. Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case-Control Studies

    Environmental health perspectives, Vol. 130, Núm. 5, pp. 57006

  6. Gene–gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer

    European Journal of Medical Research, Vol. 27, Núm. 1

  7. Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk

    Human molecular genetics, Vol. 31, Núm. 16, pp. 2831-2843

  8. I am hiQ—a novel pair of accuracy indices for imputed genotypes

    BMC Bioinformatics, Vol. 23, Núm. 1

  9. Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case–Control Studies (SYNERGY)

    Cancer Epidemiology Biomarkers and Prevention, Vol. 31, Núm. 7, pp. 1433-1441

2021

  1. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

    Genome Medicine, Vol. 13, Núm. 1